You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Biological Treatment of Bacterial Keratitis
SBC: AMEBAGONE INC Topic: NProject Summary Abstract Bacterial keratitisBKis an infection of the cornea thatif left untreatedcan cause blindnessStaphylococcus aureusSaStreptococcus pneumoniaeSpand Pseudomonas aeruginosaPaare three major causes of BK in North AmericaSymptoms of BK include painrednessinflammationand opacity of the affected cornea and loss of visual acuityAmebaGone IncAGpartnered with UW Madison Department of O ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
RetiVue DR, a point and shoot, non-mydriatic, widefield retinal camera for diabetic eye screening
SBC: RETIVUE LLC Topic: NProject Summary Over the past two decadesdiabetic retinopathyDRhas become the leading cause of adult blindness in the USaffectingof all diabetic patients and resulting in $million a year in direct medical costsVision loss due to DR is largely preventable and can be reduced by up towith appropriate eye screeningHoweverin the USless thanof diabetic patients receive a recommended yearly eye exam due ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Ultra-Compact Transmitter for Space-Based Lidar
SBC: FIBERTEK, INC. Topic: T901Fibertek, Inc. in partnership with researchers at the Pennsylvania State University Center for Innovative Materials Processing through Direct Digital Deposition (CIMP-3D) are proposing to develop a state of the art, space-qualifiable laser transmitter that meets the requirements of the flash lidar transmitter defined in the 2016 STTR subtopic T9.01, Navigation and Hazard Avoidance Sensor Technolog ...
STTR Phase II 2017 National Aeronautics and Space Administration -
Integrated Sensors for the Evaluation of Structural Integrity of Inflatable Habitats
SBC: NANOSONIC INC. Topic: T1203Inflatable pressurized habitats are envisioned as a practical way to build shelters much larger than landing craft for astronauts and their scientific operations on Mars, the moon and elsewhere. These habitats maintain their inflated shape via high-strength Vectran webbing. The piezoresistive extensometers developed through this STTR program can be directly integrated into or onto Vectran webbing ...
STTR Phase II 2017 National Aeronautics and Space Administration -
Shear Thickening Fluid Enhanced Textiles for Durable, Puncture- and Cut-Resistant Environmental Protection Garments
SBC: STF TECHNOLOGIES LLC Topic: T601This Small Business Technology Transfer Research Phase II will develop and advance the commercialization of STF-ArmorTM nanocomposite materials for use in Environmental Protection Garments (EPG) for extended exploration missions in diverse environments, including LEO, cis-lunar space, and Lunar and Martian surfaces. The Phase II research will optimize and deliver a validated prototype suit compon ...
STTR Phase II 2017 National Aeronautics and Space Administration -
A single-cell device to capture and analyze rare T-cells from solid tumors.
SBC: ISOPLEXIS CORPORATION Topic: 102Checkpoint inhibitors towards targets such as PDand PD Lare being developed to activate quiescent T cells embedded in tumors and enable them to recruit the rest of the immune system to fight a cancer massHow these new cures reactivate the relatively few Tumor Infiltrating LymphocytesTILsenabling the release of a complex message of cytokines to recruit the immune systemthus impacting treatment effi ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
A single-cell mouse proteomic system to accelerate pre-clinical immune therapeutics
SBC: ISOPLEXIS CORPORATION Topic: 100With this PhasesubmissionIsoPlexis proposes to deliver a single cell proteomic solution for ultra sensitive detection of unique correlative biomarkers in pre clinical mouse modelsin an automated system that can be used to accelerate the discovery of potential immune therapeuticsThe recent revolution in new basic science discovery is failing to translate into improved patient treatmentThe reduction ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Preclinical studies of PG70 LEAPS peptide vaccines for rheumatoid arthritis
SBC: CEL-SCI CORPORATION Topic: NIAMSCurrentlyFDA licensed pharmaceuticals used to treat rheumatoid arthritisRAfocus largely on alleviation of symptomseither through pain managementgeneral immunosuppressionor by antagonizing cytokines such as TNFDespite recent advances in biologic therapiesthese treatments do not address the underlying autoimmune conditionTo develop a peptide vaccine based therapy for RAwe used the human proteoglycan ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Large-Scale Production of High Purity Human Cortical Glutamatergic Neurons
SBC: BrainXell, Inc Topic: 101Project Summary AbstractThere exists a dire need for new and more effective drugs to treat disorders of the central nervous systemCNSespecially in mental healthThe pace of approval for new chemical entities is anemicwith an average of just three compounds per year entering the market over the lastyearsUnsurprisinglyclinical trial failure rates for CNS drug development remain greater thanand many m ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Ultrasound Enhanced Low Dose Drug Delivery: Quantifying Uptake, Retention and Biodistribution
SBC: SoundPipe, LLC Topic: NHLBIThis Direct to Phase II SBIR project addresses the need for safe and effective drug delivery after lower extremity angioplastyGlobally overmillion people suffer from peripheral arterial diseasePADBoth the disease and economic burdens of PAD are projected to grow rapidlywith the US PAD population projected to grow toM inas costs currently exceed $BThe leading cause of this growth is an aging US pop ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health